Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liver function may change how D-2570 works in the body

NCT ID NCT07715149

Recruiting now Knowledge-focused Sponsor: InventisBio Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests how the experimental drug D-2570 moves through the body and whether it is safe in people with liver problems compared to those with healthy livers. Researchers will give a single dose of D-2570 to 24 adults aged 18 to 70 and measure drug levels in the blood over time. The goal is to understand if liver impairment affects how the drug is processed, which can guide future dosing recommendations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
D-2570 tablet
What this could lead to
If successful, this study could help determine the right dose of D-2570 for people with liver problems, making future treatments safer.
What could go wrong
This is an early-stage, small study (24 people) focused on drug processing, not on treating a disease. Results may not predict effectiveness or safety in larger, diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT PARTICIPANTS HEPATIC IMPAIRMENT (HI)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Bengbu Medical University

    RECRUITING

    Bengbu, Anhui, 233004, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.